| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2013 | CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application |
| 05/08/2013 | CN103097360A Process for preparing antiviral compounds |
| 05/08/2013 | CN103097359A New compounds |
| 05/08/2013 | CN103097358A Pharmaceutical composition |
| 05/08/2013 | CN103097357A Pyrazole compound |
| 05/08/2013 | CN103097355A Novel quinoline esters useful for treating skin disorders |
| 05/08/2013 | CN103097353A Novel immunomodulator and anti inflammatory compounds |
| 05/08/2013 | CN103097340A Therapeutically active compositions and their method of use |
| 05/08/2013 | CN103097338A Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 05/08/2013 | CN103097333A Spirocyclically substituted 1,3-propane dioxide derivatives, methods for the production thereof and use of the same as medicament |
| 05/08/2013 | CN103097038A Method of coating an inorganic substrate with a stable organic layer |
| 05/08/2013 | CN103096977A Fused heterocyclic compounds as ion channel modulators |
| 05/08/2013 | CN103096929A Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof |
| 05/08/2013 | CN103096928A Prophylactic or ameliorating agent for genetic diseases |
| 05/08/2013 | CN103096908A Nasal spray |
| 05/08/2013 | CN103096904A Mitigating agent for alcohol-induced problems |
| 05/08/2013 | CN103096901A 眼用组合物 Ophthalmic compositions |
| 05/08/2013 | CN103096900A Antioxidant composition |
| 05/08/2013 | CN103096899A Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 05/08/2013 | CN103096898A Agent for the treatment of skin conditions |
| 05/08/2013 | CN103096897A Pharmaceutical compositions comprising R (+) budesonide and one or more bronchodilators |
| 05/08/2013 | CN103096896A Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same |
| 05/08/2013 | CN103096895A Niacin mimetics, and methods of use thereof |
| 05/08/2013 | CN103096894A Improved methods and compositions for safe and effective treatment of telangiectasia |
| 05/08/2013 | CN103096893A Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| 05/08/2013 | CN103096892A Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
| 05/08/2013 | CN103096891A Treatment of hepatitis c virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent |
| 05/08/2013 | CN103096890A Combination of siloxane and active ingredient for treating dental disorder |
| 05/08/2013 | CN103096889A Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives |
| 05/08/2013 | CN103096888A Coated preparation containing azosemide as active ingredient |
| 05/08/2013 | CN103096887A Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy |
| 05/08/2013 | CN103096886A Paraconic acids as pigmentation activators |
| 05/08/2013 | CN103096884A Cancer heat therapy-enhancing agent |
| 05/08/2013 | CN103096883A Treatment of fungal infections |
| 05/08/2013 | CN103096882A Transdermal drug delivery system containing donepezil |
| 05/08/2013 | CN103096881A Film preparation containing medicament with unpleasant taste |
| 05/08/2013 | CN103096880A Drug-containing film-coated particles in which unpleasant taste is masked |
| 05/08/2013 | CN103096879A Enteric Tablet |
| 05/08/2013 | CN103096870A Methods and compositions for modulating hair growth |
| 05/08/2013 | CN103096738A Composition for reducing absorption of dietary fat |
| 05/08/2013 | CN103096737A Methods of reducing blood lactate concentration |
| 05/08/2013 | CN103096734A Nutritional compositions |
| 05/08/2013 | CN103096720A Bismuth-thiols as antiseptics for agricultural, industrial and other uses |
| 05/08/2013 | CN103096718A Soluble guanylate cyclase activators |
| 05/08/2013 | CN103087923A Preparation and application of chaetomium globosum and metabolite flavipin thereof |
| 05/08/2013 | CN103087325A Ferrocenyl-containing tricyclohexyltin coordination polymer, and preparation method and application thereof |
| 05/08/2013 | CN103087277A POSS/poly lactic acid and poly(n-isopropyl acrylamide) star block copolymer preparation |
| 05/08/2013 | CN103087262A Sodium alginate-polystyrene copolymer synthesis by using ultrasound method |
| 05/08/2013 | CN103087254A Preparation method and applications of amphiphilic co-network resin |
| 05/08/2013 | CN103087141A Anti-tumor angiogenesis usage of tripterygium glycosides extractive wilforol B as KDR inhibitor |
| 05/08/2013 | CN103087140A Preparation method of ulipristal acetate polycrystal |
| 05/08/2013 | CN103087137A Glucocorticoid with sulfoalkyl group at position 21 |
| 05/08/2013 | CN103087133A Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 05/08/2013 | CN103087122A Preparation method and applications of glucoside compounds |
| 05/08/2013 | CN103087120A Preparation method and application of monosialotetrahexosylganglioside |
| 05/08/2013 | CN103087115A Ferrocenyl-containing tributyltin benzoate coordination polymer, and preparation method and application thereof |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087077A Thienopyrimidine and furopyrimidine derivative, its preparation method and application in medicines |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087061A Substituted purrocoline compound and preparation method and application thereof |
| 05/08/2013 | CN103087054A 4-pyridyl phenyl ether compounds, and preparation method and application thereof |
| 05/08/2013 | CN103087052A Thiophene derivatives and medicinal use thereof |
| 05/08/2013 | CN103087050A Aryl kinase inhibitor |
| 05/08/2013 | CN103087045A Benzimidazole heterocyclic compound, pharmaceutical composition and application thereof |
| 05/08/2013 | CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof |
| 05/08/2013 | CN103087042A Salts of sitafloxacin and pharmaceutical purposes thereof |
| 05/08/2013 | CN103087040A Penicillide derivative, preparation method thereof, and medicinal purpose thereof |
| 05/08/2013 | CN103087031A Application of bistetrahydrobenzopyrone dimer compounds in anti-cancer drugs |
| 05/08/2013 | CN103087030A Preparation method, biological activity and application of novel exo-methylene lactone tetracyclic diterpenoid compounds |
| 05/08/2013 | CN103087026A Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D |
| 05/08/2013 | CN103087024A Flavone alkylamine compounds as well as preparation method and application thereof |
| 05/08/2013 | CN103087021A Sesquiterpenes ester compound, as well as preparation method and use thereof |
| 05/08/2013 | CN103087020A Boraginaceae phenol compound and purpose thereof in preparing anticomplement medicines |
| 05/08/2013 | CN103087009A Carboxylic acid derivative compound and preparation method and application thereof |
| 05/08/2013 | CN103087001A Vanillic acid 1,3,4-oxadiazole derivatives, and preparation methods and uses thereof |
| 05/08/2013 | CN103086994A Salts of isoxazole derivatives |
| 05/08/2013 | CN103086987A (1,2,3-triazolyl) sulfonyl derivative |
| 05/08/2013 | CN103086982A Pyrimidine derivative salts |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof |
| 05/08/2013 | CN103086975A 9-hydroxymethyl-10-imidazolanthracenehydrazone, and synthetic method and application thereof |
| 05/08/2013 | CN103086972A Preparation of pyrazole-acylhydrazone compounds and application of pyrazole-acylhydrazone compounds in anticancer treatment |
| 05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
| 05/08/2013 | CN103086958A NF[kappa]B pathway activation inhibitor, preparation method thereof, pharmaceutical composition and purpose |
| 05/08/2013 | CN103086947A Phthalimide compounds with antiangiogenic activity and purpose thereof |
| 05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
| 05/08/2013 | CN103086936A Aryl compounds as PPAR ligands and their use |
| 05/08/2013 | CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use |
| 05/08/2013 | CN103086923A Hydrazine cathepsin K inhibitor and application thereof in treating osteoporosis |
| 05/08/2013 | CN103086921A 2-(4-aryloxyphenoxy)alkylamide and application thereof |
| 05/08/2013 | CN103086882A Macrocyclic diterpene compounds in fruits of Euphorbia sororia, and preparation method and use thereof |
| 05/08/2013 | CN103086864A Shikonin tetramer compound and purpose thereof in pharmacy |
| 05/08/2013 | CN103086862A Hydroxydecyl quinone derivative for treating or preventing nerve diseases |
| 05/08/2013 | CN103086861A Hydroxydecyl benzoquinone derivative and application thereof |
| 05/08/2013 | CN103086859A 2,4-dihydroxy-5,6-substituted-1-halogenobenzene derivative, synthesis method and application thereof |
| 05/08/2013 | CN103083683A Breviscapine phosphatide compound, and preparation method and application thereof |
| 05/08/2013 | CN103083682A Folic acid modified chitosan quaternary ammonium salt-taxol polymer medicine, as well as preparation method and application thereof |
| 05/08/2013 | CN103083680A Polyethylene glycol (PEG)-amino acid oligopeptide-irinotecan combo and its medicinal composition |
| 05/08/2013 | CN103083679A Preparation method of lysozyme curcumin nanoparticle |